ARTICLE | Company News
Maxia, J&J deal
January 8, 2001 8:00 AM UTC
Maxia will develop with JNJ companies R.W. Johnson Pharmaceutical Research Institute and Ortho-McNeil Pharmaceutical Inc. insulin sensitizers to treat Type II diabetes and related metabolic disorders...